Gilead Sciences
GILD
#110
Rank
NZ$314.81 B
Marketcap
NZ$253.89
Share price
0.49%
Change (1 day)
35.12%
Change (1 year)

EPS for Gilead Sciences (GILD)

EPS in 2026 (TTM): NZ$12.69

According to Gilead Sciences's latest financial reports the company's current EPS (TTM) is NZ$12.88. In 2025 the company made an earnings per share (EPS) of NZ$11.89 an increase over its 2024 EPS that were of NZ$0.66.

EPS history for Gilead Sciences from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ$12.696.77%
2025NZ$11.891702.63%
2024NZ$0.66-91.65%
2023NZ$7.9023.98%
2022NZ$6.37-25.86%
2021NZ$8.594850%
2020NZ$0.17-97.64%
2019NZ$7.360.9%
2018NZ$7.2918.71%
2017NZ$6.14-64.88%
2016NZ$17.49-18.45%
2015NZ$21.4555.28%
2014NZ$13.81296.02%
2013NZ$3.4917.89%
2012NZ$2.96

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$15.16 17.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$2.27-82.35%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
NZ$3.57-72.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$48.98 280.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$25.13 95.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
NZ$16.23 26.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
NZ$9.60-25.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
NZ$29.52 129.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$6.20-51.82%๐Ÿ‡บ๐Ÿ‡ธ USA